[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335955-105":59,"doc-detail-335955-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","emerging-mechanisms-and-implications-of-cgas-sting-signaling-in-cancer-immunotherapy-strategies","Emerging mechanisms and implications of cGAS-STING signaling in cancer immunotherapy strategies","","The review examines how cGAS-STING signaling links innate immunity with cancer development and treatment outcomes. It highlights that pathway activation triggers type I interferon (IFN-α/β) production, driving maturation, differentiation, and mobilization of immune effectors in the tumor microenvironment. STING activation also promotes tumor antigen release and presentation, supporting antitumor immunity. It further summarizes advances in pharmacological STING agonist strategies, especially when paired with immune checkpoint inhibitors, and addresses classical and non-classical agonists, their mechanisms, and therapeutic optimization despite ongoing challenges.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/emerging-mechanisms-and-implications-of-cgas-sting-signaling-in-cancer-immunotherapy-strategies/335955/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/emerging-mechanisms-and-implications-of-cgas-sting-signaling-in-cancer-immunotherapy-strategies/335955.png","ImageObject",300,407,{"name":92,"@type":93},"Patrick","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What role does the cGAS-STING pathway play in innate immunity against cancer?","Question",{"text":113,"@type":114},"It senses DNA stimuli and activates signaling that culminates in type I interferon (IFN-α/β) production, which helps coordinate antitumor immune responses in the tumor microenvironment.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does STING activation support cancer immunotherapy?",{"text":118,"@type":114},"STING activation facilitates the release and cross-presentation of tumor antigens, and it reshapes the tumor microenvironment to enhance both innate and adaptive immunity.",{"name":120,"@type":111,"acceptedAnswer":121},"What therapeutic strategies are discussed for activating the cGAS-STING pathway?",{"text":122,"@type":114},"The review focuses on classical and non-classical STING agonists, including pharmacological agonists, and emphasizes improved outcomes when STING activation is combined with immune checkpoint inhibitors.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},335955,1790014578,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":31,"preview_page_count":4},549758146520,"https://ap-avatar.wpscdn.com/avatar/80002397d8c0411e94?_k=1775819394049821470","Cancer Biol Med 2024. doi: 10.20892/j.issn.2095-3941.2023.0440  \nREVIEW  \nEmerging mechanisms and implications of cGAS-STING signaling in cancer immunotherapy strategies  \nJiawen Zhang1,2*, Sihui Yu3*, Qiao Peng1, Ping Wang1, Lan Fang1  \n1Tongji University Cancer Center, Shanghai Tenth People’s Hospital, School of Medicine, Tongji University, Shanghai 200072, China; 2 Reproductive Medicine Center, Department of Obstetrics and Gynecology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201620, China; 3 Department of Obstetrics and Gynecology, Zhongshan Hospital, Fudan University, Shanghai 200032, China  \n\n| ABSTRACT | The intricate interplay between the human immune system and cancer development underscores the central role of immunotherapy in cancer treatment. Within this landscape, the innate immune system, a critical sentinel protecting against tumor incursion, is a key player. The cyclic GMP-AMP synthase (cGAS) and stimulator of interferon genes (STING) pathway has been found to be a linchpin of innate immunity: activation of this signaling pathway orchestrates the production of type I interferon (IFN-α/β), thus fostering the maturation, differentiation, and mobilization of immune effectors in the tumor microenvironment. Furthermore, STING activation facilitates the release and presentation of tumor antigens, and therefore is an attractive target for cancer immunotherapy. Current strategies to activate the STING pathway, including use of pharmacological agonists, have made substantial advancements, particularly when combined with immune checkpoint inhibitors. These approaches have shown promise in preclinical and clinical settings, by enhancing patient survival rates. This review describes the evolving understanding of the cGAS-STING pathway’s involvement in tumor biology and therapy. Moreover, this review explores classical and non-classical STING agonists, providing insights into their mechanisms of action and potential for optimizing immunotherapy strategies. Despite challenges and complexities, the cGAS-STING pathway, a promising avenue for enhancing cancer treatment efficacy, has the potential to revolutionize patient outcomes. |\n| --- | --- |\n| KEYWORDS | cGAS-STING pathway; type I interferon; cyclic dinucleotide; STING agonist; cancer immunotherapy |\n\nIntroduction  \nThe human immune system plays critical roles in tumor development, progression, and metastasis, and is central to cancer therapy. Tumor immune surveillance relies predominantly on the innate immune system, a fundamental mechanism safeguarding the body against tumor intrusion by recognizing, regulating, and eliminating malignant cells. The efficacy of tumor antigen-specific T cells relies on signals originating  \n*These authors contributed equally to this work. Correspondence to: Ping Wang and Lan Fang  \n[E-mail: wangp@tongji.edu.cn](E-mail: wangp@tongji.edu.cn) and [lanfang@tongji.edu.cn](lanfang@tongji.edu.cn)  \nORCID ID: [https://orcid.org/0000-0002-9922-5407](https://orcid.org/0000-0002-9922-5407)  \nand [https://orcid.org/0000-0001-8477-0528](https://orcid.org/0000-0001-8477-0528)  \nReceived November 13, 2023; accepted December 14, 2023; published online January 3, 2024.  \nAvailable [at www.cancerbiomed.org](at www.cancerbiomed.org)  \n©2024 The Authors. Creative Commons Attribution-NonCommercial 4.0 International License  \nfrom the innate immune system, which greatly influence Tcells’ ability to combat tumor cells 1.  \nIn innate immunity, pattern recognition receptors (PRRs) detect molecules associated with infections, cellular stress, and tissue damage. Throughout tumor initiation and progression, cancer cells generate a plethora of damage-associated molecular patterns; these molecules interact with PRRs and subsequently trigger innate immune responses2. In innate immunity, the cyclic GMP-AMP synthase (cGAS) and stimulator of interferon genes (STING) pathway plays an instrumental role. This pathway is a dedicated ","cbCairTAXkTPuabL","https://ap.wps.com/l/cbCairTAXkTPuabL","pdf",930242,"English","# Abstract\n# Keywords\n# Introduction","[{\"question\":\"What role does the cGAS-STING pathway play in innate immunity against cancer?\",\"answer\":\"It senses DNA stimuli and activates signaling that culminates in type I interferon (IFN-α/β) production, which helps coordinate antitumor immune responses in the tumor microenvironment.\"},{\"question\":\"How does STING activation support cancer immunotherapy?\",\"answer\":\"STING activation facilitates the release and cross-presentation of tumor antigens, and it reshapes the tumor microenvironment to enhance both innate and adaptive immunity.\"},{\"question\":\"What therapeutic strategies are discussed for activating the cGAS-STING pathway?\",\"answer\":\"The review focuses on classical and non-classical STING agonists, including pharmacological agonists, and emphasizes improved outcomes when STING activation is combined with immune checkpoint inhibitors.\"}]","Emerging mechanisms and implications of cGAS-STING signaling in cancer immunotherapy strategies | PDF",1790012934]